Study reaches no conclusion on IV omeprazole for GI bleeding

11/26/2012 | Medscape (free registration)

Critically ill children given intravenous omeprazole at two dosage levels showed increased gastric pH, but researchers in Spain said it was not clear whether that reduced gastrointestinal bleeding or increased the risk of infection. Omeprazole is used to reduce bleeding risks but an effective IV dose in children has not been established.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD